1. DOSE FINDING STUDY TO ASSESS SAFETY, PK AND EFFICACY OF FIMEPINOSTAT (CUDC‐907) WITH VENETOCLAX OR RITUXIMAB PLUS BENDAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA. (12th June 2019) Authors: Younes, A.; Batlevi, C.L.; Cohen, J.B.; Kelly, K.; Landsburg, D.J.; Patel, K.; Phillips, T.; Smith, S.; Westin, J.; Ma, A.W.; Grayson, D.; Barta, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. INTERIM UPDATE FROM A PHASE 2 MULTICENTER STUDY OF TAZEMETOSTAT, AN EZH2 INHIBITOR, IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. (12th June 2019) Authors: Morschhauser, F.; Tilly, H.; Chaidos, A.; Phillips, T.; Ribrag, V.; Campbell, P.; Ghandi Laurent, D.; Jurczak, W.; McKay, P.; Opat, S.; Radford, J.; Rajarethinam, A.; Yang, J.; Howell, H.; Newberry, K.J.; Adib, D.; Salles, G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Haematuria During Nicoumalone Therapy. Issue 5215 (17th December 1960) Authors: Choudhury, A. Q. M. B.; Phillips, T. Journal: BMJ Issue: Volume 2:Issue 5215(1960) Page Start: 1802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. POLATUZUMAB VEDOTIN + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL. (17th June 2021) Authors: Bannerji, R.; Yuen, S.; Phillips, T.; Arthur, C.; Isufi, I.; Marlton, P.; Seymour, J. F.; Corradini, P.; Molinari, A.; Gritti, G.; Emmons, R.; Hirata, J.; Musick, L.; Saha, S.; Croft, B.; Flowers, C. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL. (23rd June 2022) Authors: Zelenetz, A.; Jurczak, W.; Ribrag, V.; Linton, K.; Collins, G.; Lopéz-Jiménez, J.; Reddy, N.; Mengarelli, A.; Phillips, T.; Musuraca, G.; Sheehy, O.; Li, J.; Xu, W.; Azoulay, M.; Ghalie, R.; Zinzani, P. L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY. (23rd June 2022) Authors: Woyach, J.; Flinn, I. W.; Awan, F. T.; Eradat, H.; Brander, D.; Tees, M.; Parikh, S. A.; Phillips, T.; Wang, W.; Reddy, N. M.; Farooqui, M. Z.; Byrd, J. C.; Stephens, D. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1190: OUTCOMES BY BCL2 AND MYC EXPRESSION AND REARRANGEMENTS IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA FROM THE POLARIX TRIAL. (23rd June 2022) Authors: Morschhauser, F.; Jiang, Y.; Jardin, F.; Herrera, A. F.; Sehn, L. H.; Herbaux, C.; Flowers, C.; Phillips, T.; López Guillermo, A.; Diefenbach, C.; Gregory, G. P.; Kim, A.; Barbui, A. M.; Balasubramanian, S.; Harris, W.; Hirata, J.; Paulson, J. N.; Lee, C.; Lenz, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT. (23rd June 2022) Authors: Wahlin, B. E.; Brody, J.; Phillips, T.; Costello, R.; Lugtenburg, P.; Cordoba, R.; Wang, L.; Wu, J.; Elliott, B.; Abbas, A.; Jørgensen, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1099 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R-DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT. (23rd June 2022) Authors: Cordoba, R.; Falchi, L.; Phillips, T.; de Vos, S.; Nijland, M.; Offner, F.; Bykhovski, I.; Wu, J.; Wang, L.; Rana, A.; Abrisqueta, P. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Characterizing dominant controls governing evapotranspiration within a natural saline fen in the Athabasca Oil Sands of Alberta, Canada. Issue 5 (18th September 2015) Authors: Phillips, T.; Petrone, R. M.; Wells, C. M.; Price, J. S. Journal: Ecohydrology Issue: Volume 9:Issue 5(2016) Page Start: 817 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗